MyMD to begin Phase II trial of rheumatoid arthritis therapy
The placebo-controlled and randomised study is anticipated to enrol around 60 patients with active RA.
Services - Clinical Trials
Medicure approved to enrol patients in paediatric disease trial
Immutep expands sites for INSIGHT-003 NSCLC therapy study
Chengdu Origen and Vanotech dose first subject in wet AMD therapy trial
SciSparc commences Tourette Syndrome therapy trial
Ocugen doses first patient in Stargardt disease study
Pipeline Moves: Advancement prospects plunge for Parkinson’s drug after trial termination
Takeda reports interim results from Phase III trial of cTTP therapy
